These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28065813)

  • 21. Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease.
    Bakshi N; Ross D; Krishnamurti L
    J Pain Res; 2018; 11():313-318. PubMed ID: 29445298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status.
    Salaffi F; Di Carlo M; Farah S; Atzeni F; Buskila D; Ablin JN; Häuser W; Sarzi-Puttini P
    Rheumatology (Oxford); 2020 Oct; 59(10):3042-3049. PubMed ID: 32206792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.
    Williams H; Silva S; Simmons LA; Tanabe P
    Trials; 2017 May; 18(1):218. PubMed ID: 28506281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AAAPT Diagnostic Criteria for Acute Thoracic Surgery Pain.
    Bayman EO; Curatolo M; Rahman S; Brennan TJ
    J Pain; 2021 Aug; 22(8):892-904. PubMed ID: 33848682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.
    Matthie N; Ross D; Sinha C; Khemani K; Bakshi N; Krishnamurti L
    J Natl Med Assoc; 2019 Apr; 111(2):158-168. PubMed ID: 30266214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychosocial and Functional Outcomes in Youth With Chronic Sickle Cell Pain.
    Sil S; Cohen LL; Dampier C
    Clin J Pain; 2016 Jun; 32(6):527-33. PubMed ID: 26379074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
    Brandow AM; Carroll CP; Creary S; Edwards-Elliott R; Glassberg J; Hurley RW; Kutlar A; Seisa M; Stinson J; Strouse JJ; Yusuf F; Zempsky W; Lang E
    Blood Adv; 2020 Jun; 4(12):2656-2701. PubMed ID: 32559294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a Mechanism-Based Approach to Pain Diagnosis.
    Vardeh D; Mannion RJ; Woolf CJ
    J Pain; 2016 Sep; 17(9 Suppl):T50-69. PubMed ID: 27586831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Objective Basis for Chronic Pain in Patients with Adult Sickle Cell Disease.
    Master S; Patel A; Mills G; Mansour R
    J La State Med Soc; 2016; 168(5):152-155. PubMed ID: 27797344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability and Feasibility of a Mindfulness-Based Intervention for Pain Catastrophizing among Persons with Sickle Cell Disease.
    Simmons LA; Williams H; Silva S; Keefe F; Tanabe P
    Pain Manag Nurs; 2019 Jun; 20(3):261-269. PubMed ID: 31085097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Pain: Prevalence and Management.
    Carroll CP; Brandow AM
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1151-1165. PubMed ID: 36400536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.
    Ruhl AP; Sadreameli SC; Allen JL; Bennett DP; Campbell AD; Coates TD; Diallo DA; Field JJ; Fiorino EK; Gladwin MT; Glassberg JA; Gordeuk VR; Graham LM; Greenough A; Howard J; Kato GJ; Knight-Madden J; Kopp BT; Koumbourlis AC; Lanzkron SM; Liem RI; Machado RF; Mehari A; Morris CR; Ogunlesi FO; Rosen CL; Smith-Whitley K; Tauber D; Terry N; Thein SL; Vichinsky E; Weir NA; Cohen RT; Klings ES
    Ann Am Thorac Soc; 2019 Sep; 16(9):e17-e32. PubMed ID: 31469310
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.
    Karafin MS; Simpson P; Field JJ
    Acta Haematol; 2021; 144(1):111-116. PubMed ID: 32403100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerating the development of improved analgesic treatments: the ACTION public-private partnership.
    Dworkin RH; Turk DC
    Pain Med; 2011 Jul; 12 Suppl 3():S109-17. PubMed ID: 21752182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain-measurement tools in sickle cell disease: where are we now?
    Darbari DS; Brandow AM
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):534-541. PubMed ID: 29222302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.